Table 4 highlights highly aggressive DLBCL subgrouped according to adverse prognostic factors: lack of CD20 expression, special phenotypes linked to cell of origin and CD5 expression, EBV infection, and complex karyotypes [95, 96]. The gene discussed is CD5; the disease is diffuse large B-cell lymphoma.